NR4A1 and renal cell adenocarcinoma: Knockdown of NR4A1 (and NR4A1 antagonists) decreases TXNDC5 and IDH1 and induced ROS and other stress responses in ACHN and 786-O cells (Fig 5), suggesting that NR4A1 also maintains levels of stress that facilitate RCC growth and survival.